blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3592850

EP3592850 - PREPARING AND USE OF GLU-PLASMINOGEN FROM BLOOD FRACTIONS [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  23.10.2020
Database last updated on 13.09.2024
FormerRequest for examination was made
Status updated on  13.12.2019
FormerThe international publication has been made
Status updated on  17.09.2018
Formerunknown
Status updated on  16.03.2018
Most recent event   Tooltip20.03.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
PreviPharma Consulting GmbH
Theodor-Kutzer-Ufer 1-3
68167 Mannheim / DE
[2020/03]
Inventor(s)01 / WELZ, Ricarda
Bahnhofstrasse 20
69256 Mauer / DE
02 / GERDING, Hanne Rieke
Kolmarerstrasse 17
68229 Mannheim / DE
03 / MAZUR, Marc
Grabengasse 4
69469 Weinheim / DE
04 / KIESSIG, Stephan T.
Karl-Hermann-Zahn-Str. 53/2
69168 Wiesloch / DE
05 / KARGES, Hermann E.
Sonnenweg 32
35041 Marburg / DE
 [2022/27]
Former [2020/03]01 / GRUBER, Ricarda
Bahnhofstrasse 20
69256 Mauer / DE
02 / GERDING, Hanne Rieke
Kolmarerstrasse 17
68229 Mannheim / DE
03 / MAZUR, Marc
Grabengasse 4
69469 Weinheim / DE
04 / KIESSIG, Stephan T.
Karl-Hermann-Zahn-Str. 53/2
69168 Wiesloch / DE
05 / KARGES, Hermann E.
Sonnenweg 32
35041 Marburg / DE
Representative(s)Jacobi, Markus Alexander, et al
Patentanwälte
Isenbruck Bösl Hörschler PartG mbB
Eastsite One
Seckenheimer Landstrasse 4
68163 Mannheim / DE
[2020/03]
Application number, filing date18708708.509.03.2018
[2020/03]
WO2018EP55984
Priority number, dateEP2017016010609.03.2017         Original published format: EP 17160106
[2020/03]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018162754
Date:13.09.2018
Language:EN
[2018/37]
Type: A1 Application with search report 
No.:EP3592850
Date:15.01.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 13.09.2018 takes the place of the publication of the European patent application.
[2020/03]
Search report(s)International search report - published on:EP13.09.2018
ClassificationIPC:C12N9/68, C07K1/18, A61K38/48
[2020/03]
CPC:
C12N9/6435 (EP,KR,US); A61K38/484 (EP,KR,US); C12P21/00 (US);
C12Y304/21007 (EP,KR,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/03]
TitleGerman:HERSTELLUNG UND VERWENDUNG VON GLU-PLASMINOGEN AUS BLUTFRAKTIONEN[2020/03]
English:PREPARING AND USE OF GLU-PLASMINOGEN FROM BLOOD FRACTIONS[2020/03]
French:PRÉPARATION ET UTILISATION DE GLU-PLASMINOGÈNE DE FRACTIONS SANGUINES[2020/03]
Entry into regional phase02.10.2019National basic fee paid 
02.10.2019Designation fee(s) paid 
02.10.2019Examination fee paid 
Examination procedure02.10.2019Amendment by applicant (claims and/or description)
02.10.2019Examination requested  [2020/03]
02.10.2019Date on which the examining division has become responsible
27.10.2020Despatch of a communication from the examining division (Time limit: M04)
01.03.2021Reply to a communication from the examining division
20.01.2022Despatch of a communication from the examining division (Time limit: M04)
30.05.2022Reply to a communication from the examining division
16.11.2023Despatch of a communication from the examining division (Time limit: M04)
23.01.2024Reply to a communication from the examining division
Fees paidRenewal fee
20.03.2020Renewal fee patent year 03
30.03.2021Renewal fee patent year 04
28.03.2022Renewal fee patent year 05
24.03.2023Renewal fee patent year 06
20.03.2024Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XI]GB1305504  ;
 [I]US5288489  (REICH EDWARD [US], et al);
 [XI]WO02095019  (OMRIX BIOPHARM SA [BE]);
by applicantGB1305504
 US5288489
 WO02095019
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.